These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22277307)

  • 1. Developing an efficient and reliable dry powder inhaler for pulmonary drug delivery--a review for multidisciplinary researchers.
    Islam N; Cleary MJ
    Med Eng Phys; 2012 May; 34(4):409-27. PubMed ID: 22277307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in capsule-based dry powder inhaler technology.
    Lavorini F; Pistolesi M; Usmani OS
    Multidiscip Respir Med; 2017; 12():11. PubMed ID: 28536654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an inhalation chamber and a dry powder inhaler device for administration of pulmonary medication in animal model.
    Sinha B; Mukherjee B
    Drug Dev Ind Pharm; 2012 Feb; 38(2):171-9. PubMed ID: 21721851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-use disposable dry powder inhalers for pulmonary drug delivery.
    Friebel C; Steckel H
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1359-72. PubMed ID: 21080859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
    Muralidharan P; Hayes D; Mansour HM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly reproducible powder aerosolisation for lung delivery using powder-specific electromechanical vibration.
    Crowder TM
    Expert Opin Drug Deliv; 2005 May; 2(3):579-85. PubMed ID: 16296776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative carriers in dry powder inhaler formulations.
    Rahimpour Y; Kouhsoltani M; Hamishehkar H
    Drug Discov Today; 2014 May; 19(5):618-26. PubMed ID: 24269834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry powder inhalers (DPIs)--a review of device reliability and innovation.
    Islam N; Gladki E
    Int J Pharm; 2008 Aug; 360(1-2):1-11. PubMed ID: 18583072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A novel pulmonary delivery system--dry powder inhalers].
    Tang Y; Zhu JB; Chen XJ
    Yao Xue Xue Bao; 2009 Jun; 44(6):571-4. PubMed ID: 19806884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can we bring high drug doses to the lung?
    Claus S; Weiler C; Schiewe J; Friess W
    Eur J Pharm Biopharm; 2014 Jan; 86(1):1-6. PubMed ID: 24300444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and intelligent inhaler device development.
    Tobyn M; Staniforth JN; Morton D; Harmer Q; Newton ME
    Int J Pharm; 2004 Jun; 277(1-2):31-7. PubMed ID: 15158967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, development, and technical considerations for dry powder inhaler devices.
    Dhoble S; Kapse A; Ghegade V; Chogale M; Ghodake V; Patravale V; Vora LK
    Drug Discov Today; 2024 May; 29(5):103954. PubMed ID: 38531423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel alternatives to reduce powder retention in the dry powder inhaler during aerosolization.
    Heng D; Lee SH; Ng WK; Chan HK; Kwek JW; Tan RB
    Int J Pharm; 2013 Aug; 452(1-2):194-200. PubMed ID: 23680726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of a dry powder inhaler: device design and optimisation.
    Friebel C; Steckel H; Müller BW
    J Pharm Pharmacol; 2012 Sep; 64(9):1303-15. PubMed ID: 22881442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technological and practical challenges of dry powder inhalers and formulations.
    Hoppentocht M; Hagedoorn P; Frijlink HW; de Boer AH
    Adv Drug Deliv Rev; 2014 Aug; 75():18-31. PubMed ID: 24735675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry powder inhalation: past, present and future.
    de Boer AH; Hagedoorn P; Hoppentocht M; Buttini F; Grasmeijer F; Frijlink HW
    Expert Opin Drug Deliv; 2017 Apr; 14(4):499-512. PubMed ID: 27534768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in device and formulation technologies for pulmonary drug delivery.
    Chan JG; Wong J; Zhou QT; Leung SS; Chan HK
    AAPS PharmSciTech; 2014 Aug; 15(4):882-97. PubMed ID: 24728868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing challenges in respiratory therapies.
    Yeung S; Traini D; Lewis D; Young PM
    Int J Pharm; 2018 Sep; 548(1):659-671. PubMed ID: 30033395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose dry powder inhalers to overcome the challenges of tuberculosis treatment.
    Momin MAM; Tucker IG; Das SC
    Int J Pharm; 2018 Oct; 550(1-2):398-417. PubMed ID: 30179703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.